Total Payments
$33,657
2024 Payments
$3,836
Companies
9
Transactions
61
Medicare Patients
2,578
Medicare Billing
$281,183
Payment Breakdown by Category
Other$24,900 (74.0%)
Consulting$5,115 (15.2%)
Food & Beverage$1,636 (4.9%)
Travel$1,435 (4.3%)
Research$550.00 (1.6%)
Education$21.70 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,900 | 22 | 74.0% |
| Consulting Fee | $5,115 | 2 | 15.2% |
| Food and Beverage | $1,636 | 26 | 4.9% |
| Travel and Lodging | $1,435 | 9 | 4.3% |
| Unspecified | $550.00 | 1 | 1.6% |
| Education | $21.70 | 1 | 0.1% |
Payments by Type
General
$33,107
60 transactions
Research
$550.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $32,441 | 49 | $0 (2024) |
| InspireMD Ltd | $550.00 | 1 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $236.96 | 3 | $0 (2024) |
| Boston Scientific Corporation | $168.06 | 2 | $0 (2024) |
| Abbott Laboratories | $125.27 | 1 | $0 (2023) |
| Relypsa, Inc. | $51.42 | 1 | $0 (2017) |
| Merck Sharp & Dohme LLC | $45.40 | 2 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $22.18 | 1 | $0 (2023) |
| Medtronic Vascular, Inc. | $16.91 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,836 | 8 | AstraZeneca Pharmaceuticals LP ($3,663) |
| 2023 | $3,845 | 10 | AstraZeneca Pharmaceuticals LP ($3,591) |
| 2022 | $2,239 | 6 | AstraZeneca Pharmaceuticals LP ($1,517) |
| 2021 | $6,475 | 8 | AstraZeneca Pharmaceuticals LP ($6,475) |
| 2020 | $7,784 | 8 | AstraZeneca Pharmaceuticals LP ($7,767) |
| 2019 | $3,383 | 9 | AstraZeneca Pharmaceuticals LP ($3,383) |
| 2018 | $6,044 | 11 | AstraZeneca Pharmaceuticals LP ($6,044) |
| 2017 | $51.42 | 1 | Relypsa, Inc. ($51.42) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $104.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Travel and Lodging | In-kind items and services | $36.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 04/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: Cardio-renal | ||||||
| 03/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $122.78 | General |
| Category: Cardio-renal | ||||||
| 11/27/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $82.24 | General |
| Category: Cardio-renal | ||||||
| 11/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/10/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $135.00 | General |
| 10/19/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $116.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $39.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.18 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/21/2023 | Abbott Laboratories | OPTIS (Device) | Food and Beverage | In-kind items and services | $125.27 | General |
| Category: Vascular | ||||||
| 03/03/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/01/2022 | InspireMD Ltd | CGuard (Device) | — | Cash or cash equivalent | $550.00 | Research |
| Study: Usability Study • Category: Cardiology | ||||||
| 05/25/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $21.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/17/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $92.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/15/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/24/2022 | Boston Scientific Corporation | General - Vascular Access (Device) | Food and Beverage | In-kind items and services | $149.70 | General |
| Category: General - Vascular Access_IC | ||||||
| 02/07/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $475.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Usability Study | InspireMD Ltd | $550.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 588 | 852 | $268,079 | $64,165 |
| 2022 | 15 | 697 | 990 | $305,891 | $74,881 |
| 2021 | 15 | 695 | 1,086 | $317,130 | $75,792 |
| 2020 | 16 | 598 | 899 | $293,619 | $66,345 |
Total Patients
2,578
Total Services
3,827
Medicare Billing
$281,183
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 121 | 196 | $65,464 | $14,767 | 22.6% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 14 | 14 | $21,140 | $8,647 | 40.9% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 16 | 17 | $30,005 | $8,102 | 27.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 37 | $31,783 | $6,620 | 20.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 46 | $28,244 | $6,589 | 23.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 42 | $13,482 | $4,030 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 54 | 68 | $15,232 | $3,580 | 23.5% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 22 | 24 | $14,784 | $3,314 | 22.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $14,925 | $2,931 | 19.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 159 | 284 | $8,520 | $1,838 | 21.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 15 | $6,720 | $1,636 | 24.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 18 | 20 | $4,460 | $1,372 | 30.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 70 | 74 | $13,320 | $739.11 | 5.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 123 | 192 | $64,128 | $14,167 | 22.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 21 | 25 | $44,125 | $11,918 | 27.0% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2022 | 11 | 11 | $16,610 | $7,001 | 42.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 41 | $25,174 | $6,654 | 26.4% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 40 | 40 | $24,640 | $6,177 | 25.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 14 | 29 | $24,911 | $5,343 | 21.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 30 | 59 | $18,939 | $5,065 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 67 | 87 | $19,488 | $4,572 | 23.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 20 | 24 | $10,752 | $3,028 | 28.2% |
| 93456 | Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 13 | 13 | $10,257 | $3,014 | 29.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 34 | 38 | $8,474 | $2,206 | 26.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 173 | 314 | $9,420 | $2,035 | 21.6% |
About Dr. Mohamed Khan, MD
Dr. Mohamed Khan, MD is a Cardiovascular Disease healthcare provider based in Brighton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588740054.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohamed Khan, MD has received a total of $33,657 in payments from pharmaceutical and medical device companies, with $3,836 received in 2024. These payments were reported across 61 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($24,900).
As a Medicare-enrolled provider, Khan has provided services to 2,578 Medicare beneficiaries, totaling 3,827 services with total Medicare billing of $281,183. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Brighton, MA
- Active Since 10/27/2006
- Last Updated 05/28/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1588740054
Products in Payments
- FARXIGA (Drug) $23,229
- BRILINTA (Drug) $6,137
- LOKELMA (Drug) $2,941
- CGuard (Device) $550.00
- Kerendia (Drug) $236.96
- General - Vascular Access (Device) $149.70
- OPTIS (Device) $125.27
- Veltassa (Drug) $51.42
- VERQUVO (Drug) $45.40
- LifeVest (Device) $22.18
- WATCHMAN FLX (Device) $18.36
- 3F (Device) $16.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brighton
Michael Orlov, M.d, M.D
Cardiovascular Disease — Payments: $49,348
Cardiovascular Disease $49,348
Joseph Carrozza, M.d, M.D
Cardiovascular Disease — Payments: $25,501
Cardiovascular Disease $25,501
Douglas Losordo, Md, MD
Cardiovascular Disease — Payments: $17,893
Cardiovascular Disease $17,893
Dr. Ayodeji Dina, M.d, M.D
Cardiovascular Disease — Payments: $12,430
Cardiovascular Disease $12,430
Donald Rabor, Md, MD
Cardiovascular Disease — Payments: $11,153
Cardiovascular Disease $11,153
Brian Allen, M.d, M.D
Cardiovascular Disease — Payments: $9,799
Cardiovascular Disease $9,799